Accendra Health Publishes Q3 2026 Earnings Supplemental Presentation

PUBT · 20h ago
Accendra Health Publishes Q3 2026 Earnings Supplemental Presentation
  • Accendra Health reported third-quarter 2026 net revenue of $602 million, down from $697 million a year earlier.
  • Adjusted EBITDA fell to $48 million from $92 million.
  • Net loss from continuing operations widened to $18 million from $6 million.
  • Free cash flow declined to $6 million from $29 million.
  • Nine-month adjusted EBITDA dropped to $166 million from $285 million; free cash flow turned negative at $21 million versus positive $80 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accendra Health Inc. published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.